MLPA and MAPH: New techniques for detection of gene deletions

被引:207
作者
Sellner, LN
Taylor, GR
机构
[1] Princess Margaret Hosp, Genet Serv Western Australia, Mol Genet Lab, Perth, WA 6008, Australia
[2] St James Univ Hosp, Mutat Detect Facil, Reg Genet Serv, Leeds LS9 7TF, W Yorkshire, England
[3] St James Univ Hosp, Mutat Detect Facil, Canc Res UK, Leeds LS9 7TF, W Yorkshire, England
关键词
MLPA; MAPH; gene dosage; deletion; duplication; mutation detection;
D O I
10.1002/humu.20035
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Screening for deletions of all or part of genes poses a challenge in the diagnostic laboratory. Numerous methods are available for detecting deletions of a few base pairs or very large deletions, but difficulties arise in detecting deletions of a few kilobases. Two new techniques have recently been described that allow detection of such mid, size deletions by simultaneously screening for the loss or duplication of up to 40 target sequences. These are the multiplex amplification and probe hybridization (MAPH) and the multiplex ligation-dependent probe amplification (MLPA). Both rely on sequence, specific probe hybridization to genomic DNA, followed by amplification of the hybridized probe, and semi, quantitative analysis of the resulting PCR products. The relative peak heights or band intensities from each target indicate their initial concentration. The two techniques differ in the ease with which probes can be generated in house, and the labor intensity of performing the assay. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:413 / 419
页数:7
相关论文
共 22 条
  • [1] Measurement of locus copy number by hybridisation with amplifiable probes
    Armour, JAL
    Sismani, C
    Patsalis, PC
    Cross, G
    [J]. NUCLEIC ACIDS RESEARCH, 2000, 28 (02) : 605 - 609
  • [2] Choi SW, 2002, CLIN CANCER RES, V8, P2311
  • [3] Universal DNA array detection of small insertions and deletions in BRCA1 and BRCA2
    Favis, R
    Day, JP
    Gerry, NP
    Phelan, C
    Narod, S
    Barany, F
    [J]. NATURE BIOTECHNOLOGY, 2000, 18 (05) : 561 - 564
  • [4] Significant contribution of large BRCA1 gene rearrangements in 120 French breast and ovarian cancer families
    Gad, S
    Caux-Moncoutier, V
    Pagès-Berhouet, S
    Gauthier-Villars, M
    Coupier, I
    Pujol, P
    Frénay, M
    Gilbert, B
    Maugard, C
    Bignon, YJ
    Chevrier, A
    Rossi, A
    Fricker, JP
    Nguyen, TD
    Demange, L
    Aurias, A
    Bensimon, A
    Stoppa-Lyonnet, D
    [J]. ONCOGENE, 2002, 21 (44) : 6841 - 6847
  • [5] Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach
    Gille, JJP
    Hogervorst, FBL
    Pals, G
    Wijnen, JT
    van Schooten, RJ
    Dommering, CJ
    Meijer, GA
    Craanen, ME
    Nederlof, PM
    de Jong, D
    McElgunn, CJ
    Schouten, JP
    Menko, FH
    [J]. BRITISH JOURNAL OF CANCER, 2002, 87 (08) : 892 - 897
  • [6] The development and clinical use of trastuzumab (Herceptin)
    Harries, M
    Smith, I
    [J]. ENDOCRINE-RELATED CANCER, 2002, 9 (02) : 75 - 85
  • [7] Hogervorst FBL, 2003, CANCER RES, V63, P1449
  • [8] High throughput screening of human subtelomeric DNA for copy number changes using multiplex amplifiable probe hybridisation (MAPH)
    Hollox, EJ
    Atia, T
    Cross, G
    Parkin, T
    Armour, JAL
    [J]. JOURNAL OF MEDICAL GENETICS, 2002, 39 (11) : 790 - 795
  • [9] KOENIG M, 1989, AM J HUM GENET, V45, P498
  • [10] Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer families
    Montagna, M
    Palma, MD
    Menin, C
    Agata, S
    De Nicolo, A
    Chieco-Bianchi, L
    D'Andrea, E
    [J]. HUMAN MOLECULAR GENETICS, 2003, 12 (09) : 1055 - 1061